ABBV · AbbVie Inc. · Analyst Estimates
$286.00
+0.36 (+0.13%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$506.00B
Shares
1.77B
Volume · Oct 26
4.32M
Avg daily vol (3M)
4.86M
Analyst Estimates
Compare analyst forecasts for AbbVie Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-24 23:15 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
13.81
|
13.96
|
14.25
|
27
|
13.96
|
14.01
|
14.01
|
14.15
|
8
|
10
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
67.25B
|
67.63B
|
67.99B
|
24
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
15.17
|
16.20
|
17.65
|
25
|
16.21
|
16.27
|
16.28
|
16.33
|
5
|
6
|
2
|
3
|
|
Revenue
USD
Publication date not stated |
70.99B
|
73.59B
|
75.00B
|
22
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
3.61
|
3.78
|
3.86
|
21
|
3.79
|
3.84
|
3.84
|
3.85
|
7
|
8
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
17.20B
|
17.35B
|
17.58B
|
20
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
3.77
|
3.89
|
4.18
|
19
|
3.88
|
3.87
|
3.87
|
4.00
|
4
|
5
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
18.11B
|
18.31B
|
18.51B
|
17
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1551152
CUSIP
00287Y109
13F (30d)
1507 filings
1452 filers
Visit website
Investor relations